ResearcherGeorgia Institute of TechnologyActive in the last 2 years
Rafael V. Davalos
Matched on ORCID iD 0000-0003-1503-9509; OpenAlex author ID A5027511386. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2019: 1 paper · 2020: none · 2021: 2 papers · 2022: 1 paper · 2023: none · 2024: 2 papers · 2025: none · 2026: 1 paper
Papers 7
- Novel Combination of Irreversible Electroporation and Allogenic Chimeric Antigen Receptor T-Cell Therapy Synergizes Therapeutic Outcomes in a Preclinical Human… Last author DOI 10.34133/research.1105↗
- Electro-antibacterial therapy (EAT) to enhance intracellular bacteria clearance in pancreatic cancer cells. Co-author DOI 10.1016/j.bioelechem.2024.108669↗
- Irreversible electroporation promotes a pro-inflammatory tumor microenvironment and anti-tumor immunity in a mouse pancreatic cancer model. Co-author DOI 10.3389/fimmu.2024.1352821↗
- Exploration of Novel Pathways Underlying Irreversible Electroporation Induced Anti-Tumor Immunity in Pancreatic Cancer. Co-author DOI 10.3389/fonc.2022.853779↗
- Establishing an immunocompromised porcine model of human cancer for novel therapy development with pancreatic adenocarcinoma and irreversible electroporation. Co-author DOI 10.1038/s41598-021-87228-5↗
- Histotripsy Ablation Alters the Tumor Microenvironment and Promotes Immune System Activation in a Subcutaneous Model of Pancreatic Cancer. Co-author DOI 10.1109/tuffc.2021.3078094↗
- Post-treatment analysis of irreversible electroporation waveforms delivered to human pancreatic cancer patients. Last author DOI 10.1109/embc.2019.8857259↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Irving C Allen · 4 shared papers, 2021–2024 · strength 0.59
- Paper Exploration of Novel Pathways Underlying Irreversible Electroporation Induced Anti-Tumor Immunity in Pancreatic Cancer. DOI 10.3389/fonc.2022.853779↗
- Paper Irreversible electroporation promotes a pro-inflammatory tumor microenvironment and anti-tumor immunity in a mouse panc… DOI 10.3389/fimmu.2024.1352821↗
- Paper Histotripsy Ablation Alters the Tumor Microenvironment and Promotes Immune System Activation in a Subcutaneous Model of… DOI 10.1109/tuffc.2021.3078094↗
- Natalie Beitel-White · 4 shared papers, 2019–2024 · strength 0.57
- Paper Irreversible electroporation promotes a pro-inflammatory tumor microenvironment and anti-tumor immunity in a mouse panc… DOI 10.3389/fimmu.2024.1352821↗
- Paper Post-treatment analysis of irreversible electroporation waveforms delivered to human pancreatic cancer patients. DOI 10.1109/embc.2019.8857259↗
- Paper Histotripsy Ablation Alters the Tumor Microenvironment and Promotes Immune System Activation in a Subcutaneous Model of… DOI 10.1109/tuffc.2021.3078094↗
- Alissa Hendricks-Wenger · 3 shared papers, 2021–2024 · strength 0.41
- Paper Irreversible electroporation promotes a pro-inflammatory tumor microenvironment and anti-tumor immunity in a mouse panc… DOI 10.3389/fimmu.2024.1352821↗
- Paper Histotripsy Ablation Alters the Tumor Microenvironment and Promotes Immune System Activation in a Subcutaneous Model of… DOI 10.1109/tuffc.2021.3078094↗
- Paper Establishing an immunocompromised porcine model of human cancer for novel therapy development with pancreatic adenocarc… DOI 10.1038/s41598-021-87228-5↗
- Khan Mohammad Imran · 2 shared papers, 2022–2024 · strength 0.37
- Paper Exploration of Novel Pathways Underlying Irreversible Electroporation Induced Anti-Tumor Immunity in Pancreatic Cancer. DOI 10.3389/fonc.2022.853779↗
- Paper Irreversible electroporation promotes a pro-inflammatory tumor microenvironment and anti-tumor immunity in a mouse panc… DOI 10.3389/fimmu.2024.1352821↗
- Edward J. Jacobs · 1 shared paper, 2026 · strength 0.36
- Margaret A. Nagai-Singer · 2 shared papers, 2021–2022 · strength 0.29
- Paper Exploration of Novel Pathways Underlying Irreversible Electroporation Induced Anti-Tumor Immunity in Pancreatic Cancer. DOI 10.3389/fonc.2022.853779↗
- Paper Establishing an immunocompromised porcine model of human cancer for novel therapy development with pancreatic adenocarc… DOI 10.1038/s41598-021-87228-5↗
- Scott S. Verbridge · 1 shared paper, 2024 · strength 0.26
- Josie L. Duncan · 1 shared paper, 2024 · strength 0.26
- Robert C.G. Martin · 1 shared paper, 2019 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.